New drug approvals took a nosedive in 2016. Here are the 22 that made the grade
As the saying goes, what goes up must come down, and to the biopharma industry's chagrin, that’s exactly what happened to new drug approvals in 2016. Last year, the FDA logged 22 new drug OKs, a paltry total compared with the 45 that won a green light in 2015 and 41 in 2014.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063